Ticker League

Cash on Hand for Gilead Sciences (GILD)

As of · Reported

Metric

Latest period

$9.82B

YoY change

-8.3%

5Y CAGR

+7.4%

Peak year (2018)

$30.09B

Cash on Hand history chart for Gilead Sciences (GILD) from 1990 to 2025

Latest: $10.61B

Cash on Hand growth chart for Gilead Sciences (GILD) from 1990 to 2025

Latest: -8.3%

Cash on Hand history table for Gilead Sciences (GILD) from 1990 to 2025

  • 2025$10.61B-8.3%
  • 2024$11.57B+59.3%
  • 2023$7.26B+13.8%
  • 2022$6.38B-2.1%
  • 2021$6.52B-12.0%
  • 2020$7.41B-69.6%
  • 2019$24.35B-19.1%
  • 2018$30.09B+17.9%
  • 2017$25.51B+114.5%
  • 2016$11.89B-18.6%
  • 2015$14.61B+44.2%
  • 2014$10.13B+375.0%
  • 2013$2.13B+14.5%
  • 2012$1.86B-81.2%
  • 2011$9.90B+371.7%
  • 2010$2.10B+26.7%
  • 2009$1.66B-7.4%
  • 2008$1.79B+52.7%
  • 2007$1.17B+25.1%
  • 2006$936.85M-59.5%
  • 2005$2.31B+84.3%
  • 2004$1.25B+77.4%
  • 2003$707.00M-25.0%
  • 2002$942.37M+61.7%
  • 2001$582.85M+13.6%
  • 2000$512.88M+74.2%
  • 1999$294.39M+191.2%
  • 1998$101.10M+215.9%
  • 1997$32.00M-75.8%
  • 1996$132.00M+381.8%
  • 1995$27.40M-9.9%
  • 1994$30.40M—
  • 1992$2.10M-97.6%
  • 1991$87.90M+753.4%
  • 1990$10.30M—

Cash on Hand values are taken from Gilead Sciences's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Cash on Hand at Gilead Sciences (GILD)

According to Gilead Sciences's latest reported financial statements, the company's latest reported cash and short-term investments is $9.82B. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

In 2025, Gilead Sciences (GILD) cash and short-term investments totalled $10.61B – declined 8.3% year-over-year.

Gilead Sciences cash and short-term investments has grown on net over the period, with a +7.4% compound annual growth rate over 2020–2025 (5 years).

Gilead Sciences cash and short-term investments peaked at $30.09B in 2018; the latest annual figure is $10.61B in 2025 (64.8% below peak).

$30.09B stands as the all-time-high annual cash and short-term investments, posted in 2018, against a low of $2.10M during 1992.

Gilead Sciences Cash on Hand by Year

Gilead Sciences Cash on Hand 2025: $10.61B

In 2025, Gilead Sciences reported cash and short-term investments of $10.61B, declined 8.3% below 2024.

Gilead Sciences Cash on Hand 2024: $11.57B

Gilead Sciences cash and short-term investments in 2024 was $11.57B, surged 59.3% from 2023.

Gilead Sciences Cash on Hand 2023: $7.26B

2023's cash and short-term investments for Gilead Sciences came in at $7.26B, grew 13.8% from 2022.

Gilead Sciences Cash on Hand 2022: $6.38B

Gilead Sciences posted cash and short-term investments of $6.38B in 2022, edged down 2.1% below 2021.

Gilead Sciences Cash on Hand 2021: $6.52B

Gilead Sciences cash and short-term investments in 2021 was $6.52B.

See more financial history for Gilead Sciences (GILD).

Sector peers by Cash on Hand

Healthcare peers of Gilead Sciences (GILD), ranked by their latest cash and short-term investments

Frequently asked questions

Gilead Sciences (GILD) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation